Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether a novel dosage form of a prednisolone
ester, called COLAL-PRED®, is useful in the treatment of ulcerative colitis.